SARS-CoV-2 infection among healthcare workers in Turkiye: A systematic review and meta-analysis

被引:0
|
作者
Aral, Ayse Onal [1 ]
机构
[1] Ankara Golbasi State Hosp, Dept Pulm Dis, Ankara, Turkiye
关键词
Healthcare workers; meta-analysis; prevalence; risk factors; SARS-CoV-2; systematic review; Turkiye; COVID-19; INFECTION; RISK-FACTORS; PROFESSIONALS; PREVALENCE;
D O I
10.14744/ejp.2023.1001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BACKGROUND AND AIM: The pandemic caused by severe acute respiratory syndrome coro-navirus 2 (SARS-CoV-2) is still ongoing, despite it has been three years since the first case was diagnosed in China in 2019. Healthcare workers (HCWs) are at the frontline in the fight against the virus, making them more susceptible to contacting the disease. This review aims to describe the clinical outcomes and risk factors for SARS-CoV-2 infection among HCWs in Turkiye before the vaccination campaign started in the country.METHODS: Relevant studies conducted from December 2019 to January 13, 2021, were in-cluded. A literature search spanning from April 25, 2022 to May 29, 2022, was conducted in six databases. A random-effect model or fixed-effect model was used for meta-analysis. Publication bias was assessed with Egger's test. A total of 19 studies were included.RESULTS: The total number of HCWs diagnosed with SARS-CoV-2 infection was 2,367, with a mean age of 35.238 (95% CI 33.878, 36.598). The proportion of females was 63% (95% CI 58.5, 67.2). The estimated pooled prevalence of SARSCoV-2 infection was 9.3% (95% CI 6.2, 13.6) by polymerase chain reaction (PCR) for the first two months and 3.1% (95% CI 2.3, 4.1) by antibody test for the third and fourth month of the pandemic. The proportion of infected HCWs was 17.0% (95% CI 14.5, 19.9) between the fourth and eighth months and 19.0% (95% CI 17.3, 20.8) at the eighth month of the pandemic by antibody test. The rate of hospitalization was 10% (95% CI 5.5, 17.5). The most prevalent symptom was myalgia with a rate of 41.2% (95% CI 29.7, 53.8). Hypertension was the most prevalent comorbidity with a rate of 5.9% (95% CI 3.2, 10.8). Inappropriate use of personal protective equiment (PPE) and more contact with patients were among the risk factors.CONCLUSIONS: The results of this study showed that the rate of infected HCWs had increased exponentially from the beginning until the eighth month of the pandemic and was much higher com-pared to the general population in our country.
引用
收藏
页码:67 / 79
页数:13
相关论文
共 50 条
  • [31] Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis
    Figueiredo, Gerusa Maria
    Tengan, Fatima Mitiko
    Campos, Sergio Roberto
    Luna, Expedito Jose
    CLINICS, 2023, 78
  • [32] Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
    Ng, Wern Hann
    Tipih, Thomas
    Makoah, Nigel A.
    Vermeulen, Jan-G
    Goedhals, Dominique
    Sempa, Joseph B.
    Burt, Felicity J.
    Taylor, Adam
    Mahalingam, Suresh
    MBIO, 2021, 12 (01): : 1 - 12
  • [33] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
    Rostami, Ali
    Sepidarkish, Mahdi
    Leeflang, Mariska M. G.
    Riahi, Seyed Mohammad
    Shiadeh, Malihe Nourollahpour
    Esfandyari, Sahar
    Mokdad, Ali H.
    Hotez, Peter J.
    Gasser, Robin B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (03) : 331 - 340
  • [34] Child transmission of SARS-CoV-2: a systematic review and meta-analysis
    Sarah L Silverberg
    Bei Yuan Zhang
    Shu Nan Jessica Li
    Conrad Burgert
    Hennady P Shulha
    Vanessa Kitchin
    Laura Sauvé
    Manish Sadarangani
    BMC Pediatrics, 22
  • [35] Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis
    Madewell, Zachary J.
    Yang, Yang
    Longini, Ira M., Jr.
    Halloran, M. Elizabeth
    Dean, Natalie E.
    JAMA NETWORK OPEN, 2020, 3 (12)
  • [36] Some of us are most at risk: Systematic review and meta-analysis of correlates of depressive symptoms among healthcare workers during the SARS-CoV-2 outbreak
    Crocamo, Cristina
    Bachi, Bianca
    Calabrese, Angela
    Callovini, Tommaso
    Cavaleri, Daniele
    Cioni, Riccardo M.
    Moretti, Federico
    Bartoli, Francesco
    Carr, Giuseppe
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 131 : 912 - 922
  • [37] Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
    Stadler, Eva
    Li Chai, Khai
    Schlub, Timothy E.
    Cromer, Deborah
    Khan, Shanchita R.
    Polizzotto, Mark N.
    Kent, Stephen J.
    Beecher, Claire
    White, Heath
    Turner, Tari
    Skoetz, Nicole
    Estcourt, Lise
    Mcquilten, Zoe K.
    Wood, Erica M.
    Khoury, David S.
    Davenport, Miles P.
    LANCET MICROBE, 2023, 4 (11): : 883 - 892
  • [38] Within-host dynamics of SARS-CoV-2 infection: A systematic review and meta-analysis
    Du, Zhanwei
    Wang, Shuqi
    Bai, Yuan
    Gao, Chao
    Lau, Eric H. Y.
    Cowling, Benjamin J.
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (06) : 3964 - 3971
  • [39] Telomere length in subjects with and without SARS-CoV-2 infection: a systematic review and meta-analysis
    Perez-Lopez, Faustino Ramon
    Fernandez-Alonso, Ana Maria
    Ulloque-Badaracco, Juan Ramiro
    Benites-Zapata, Vicente Aleixandre
    Varikasuvu, Seshadri Reddy
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (09):
  • [40] Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis
    Starke, Karla Romero
    Kaboth, Pauline
    Rath, Natalie
    Reissig, David
    Kaempf, Daniel
    Nienhaus, Albert
    Seidler, Andreas
    JOURNAL OF INFECTION, 2024, 89 (03)